CP-532,903

CP-532,903
Names
	IUPAC name 6-{[(2,5-Dichlorophenyl)methyl]amino}-9H-purin-9-yl 3-amino-3-deoxy-N-methyl-β-D-ribofuranosiduronamide
	Systematic IUPAC name (2S,3S,4R,5R)-3-Amino-5-(6-{[(2,5-dichlorophenyl)methyl]amino}-9H-purin-9-yl)-4-hydroxy-N5-methyloxolane-2-carboxamide
	Other names CP-532,903
Identifiers
CAS Number	457612-59-8 ;
3D model (JSmol)	Interactive image; Interactive image;
ChemSpider	8654410 ;
PubChem CID	10479002;
UNII	J233Z26QH5 ;
CompTox Dashboard (EPA)	DTXSID40440587 ;
	InChI InChI=1S/C18H19Cl2N7O3/c1-22-17(29)14-11(21)13(28)18(30-14)27-7-26-12-15(24-6-25-16(12)27)23-5-8-4-9(19)2-3-10(8)20/h2-4,6-7,11,13-14,18,28H,5,21H2,1H3,(H,22,29)(H,23,24,25)/t11-,13+,14-,18+/m0/s1 Key: WFRYPIJMCFQCGT-MHMFGPJMSA-N ; InChI=1/C18H19Cl2N7O3/c1-22-17(29)14-11(21)13(28)18(30-14)27-7-26-12-15(24-6-25-16(12)27)23-5-8-4-9(19)2-3-10(8)20/h2-4,6-7,11,13-14,18,28H,5,21H2,1H3,(H,22,29)(H,23,24,25)/t11-,13+,14-,18+/m0/s1 Key: WFRYPIJMCFQCGT-MHMFGPJMBE;
	SMILES Clc3ccc(Cl)cc3CNc(c1nc4)ncnc1n4C(C(O)C2N)OC2C(=O)NC; Clc1cc(c(Cl)cc1)CNc4ncnc2c4ncn2[C@@H]3O[C@H](C(=O)NC)[C@@H](N)[C@H]3O;
Properties
Chemical formula	C18H19Cl2N7O3
Molar mass	452.30 g·mol−1
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). verify (what is ?) Infobox references

CP-532,903 is a selective adenosine A₃ subtype receptor agonist. It has antiinflammatory effects and has been shown to reduce superoxide generation in damaged tissues,^[1] and protects against tissue damage following myocardial ischemia,^[2] mediated via an interaction with ATP-sensitive potassium channels.^[3]

References

^ Van Der Hoeven, D.; Wan, T. C.; Auchampach, J. A. (2008). "Activation of the A(3) adenosine receptor suppresses superoxide production and chemotaxis of mouse bone marrow neutrophils". Molecular Pharmacology. 74 (3): 685–696. doi:10.1124/mol.108.048066. PMC 2574951. PMID 18583455.
^ Tracey, W. R.; Magee, W. P.; Oleynek, J. J.; Hill, R. J.; Smith, A. H.; Flynn, D. M.; Knight, D. R. (2003). "Novel N6-substituted adenosine 5'-N-methyluronamides with high selectivity for human adenosine A3 receptors reduce ischemic myocardial injury". American Journal of Physiology. Heart and Circulatory Physiology. 285 (6): H2780-7. doi:10.1152/ajpheart.00411.2003. PMID 12919933.
^ Wan, Tina C.; Ge, Zhi-Dong; Tampo, Akihito; Mio, Yasushi; Bienengraeber, Martin W.; Tracey, W. Ross; Gross, Garrett J.; Kwok, Wai-Meng; Auchampach, John A. (2008). "The A₃ Adenosine Receptor Agonist CP-532,903 [ N ⁶-(2,5-Dichlorobenzyl)-3′-aminoadenosine-5′- N -methylcarboxamide] Protects against Myocardial Ischemia/Reperfusion Injury via the Sarcolemmal ATP-Sensitive Potassium Channel". Journal of Pharmacology and Experimental Therapeutics. 324: 234–243. doi:10.1124/jpet.107.127480. PMC 2435594. PMID 17906066.

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.